Key Record Dates
ClinicalTrials.gov Identifier: | NCT05400226 |
---|---|
Brief Title: | Phase 2 Study of VGT-309 in Lung Cancer |
First Submitted : | May 26, 2022 |
First Submitted that Met QC Criteria : | May 26, 2022 |
First Posted : | June 1, 2022 |
Last Update Submitted that Met QC Criteria : | November 28, 2023 |
Last Update Posted : | November 29, 2023 |